410 related articles for article (PubMed ID: 21615270)
1. Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease.
Ghosh N; Ghosh R; Mandal SC
Free Radic Res; 2011 Aug; 45(8):888-905. PubMed ID: 21615270
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
[TBL] [Abstract][Full Text] [Related]
4. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
[TBL] [Abstract][Full Text] [Related]
5. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid.
Cui X; Zuo P; Zhang Q; Li X; Hu Y; Long J; Packer L; Liu J
J Neurosci Res; 2006 Jun; 83(8):1584-90. PubMed ID: 16555301
[TBL] [Abstract][Full Text] [Related]
6. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants.
Cui K; Luo X; Xu K; Ven Murthy MR
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):771-99. PubMed ID: 15363603
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
8. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.
Maes M; Galecki P; Chang YS; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):676-92. PubMed ID: 20471444
[TBL] [Abstract][Full Text] [Related]
9. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
[TBL] [Abstract][Full Text] [Related]
10. Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds.
Behl C; Moosmann B
Biol Chem; 2002; 383(3-4):521-36. PubMed ID: 12033440
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E and other endogenous antioxidants in the central nervous system.
Vatassery GT
Geriatrics; 1998 Sep; 53 Suppl 1():S25-7. PubMed ID: 9745632
[TBL] [Abstract][Full Text] [Related]
12. Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases.
Calabrese V; Cornelius C; Mancuso C; Barone E; Calafato S; Bates T; Rizzarelli E; Kostova AT
Front Biosci (Landmark Ed); 2009 Jan; 14(1):376-97. PubMed ID: 19273073
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.
Lin MT; Beal MF
Nature; 2006 Oct; 443(7113):787-95. PubMed ID: 17051205
[TBL] [Abstract][Full Text] [Related]
14. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria.
Herrera F; Martin V; García-Santos G; Rodriguez-Blanco J; Antolín I; Rodriguez C
J Neurochem; 2007 Feb; 100(3):736-46. PubMed ID: 17263795
[TBL] [Abstract][Full Text] [Related]
15. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and neurodegeneration: where are we now?
Halliwell B
J Neurochem; 2006 Jun; 97(6):1634-58. PubMed ID: 16805774
[TBL] [Abstract][Full Text] [Related]
17. Melatonin oxidative stress and neurodegenerative diseases.
Srinivasan V
Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
[TBL] [Abstract][Full Text] [Related]
18. New concept in nutrition for the maintenance of the aging eye redox regulation and therapeutic treatment of cataract disease; synergism of natural antioxidant imidazole-containing amino acid-based compounds, chaperone, and glutathione boosting agents: a systemic perspective on aging and longevity emerged from studies in humans.
Babizhayev MA
Am J Ther; 2010; 17(4):373-89. PubMed ID: 20463577
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.
Kasote DM; Hegde MV; Katyare SS
Biofactors; 2013; 39(4):392-406. PubMed ID: 23460132
[TBL] [Abstract][Full Text] [Related]
20. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
